FDA News Summary for January 10, 2025 “`

325ea7b986b458c8d51b5ae507d2625a FDA Roundup: January 10, 2025

SILVER SPRING, Md., Jan. 10, 2025 — The U.S. Food and Drug Administration offers a summary of recent agency news:

  • The FDA released a new strategy for infant formula, building on a 2023 plan responding to the February 2022 recall and subsequent shortage. The FDA collaborated with the National Academies of Sciences, Engineering, and Medicine to research long-term solutions for a more resilient infant formula supply. The strategy outlines actions taken since 2023. Deputy Commissioner for Human Foods, Jim Jones, stated, “Consumers deserve to have the utmost confidence that infant formula available in the U.S. is safe and nutritious. We are proud of the actions we have taken to protect the integrity of the infant formula supply chain. We also recognize that additional efforts are needed and are committed to continued stakeholder engagement and increased oversight of the U.S. infant formula market.”
  • The FDA published “,” an FDA Voices article by Patrizia Cavazzoni, M.D., Director of the Center for Drug Evaluation and Research (CDER). This article highlights key findings from the CDER report, which details drug approvals expected to significantly impact public health in 2024, including therapies for schizophrenia, new antibiotics, and various cancers.
  • The FDA issued a Request For Comments (RFC) seeking public input on monitoring needs for the National Antimicrobial Resistance Monitoring System (NARMS) 2026-2030 Strategic Plan. Details on submitting comments and specific questions are available in the RFC document. The comment period ends March 26, 2025.
  • The FDA released a Consumer Update on the importance of maintaining a personal medication list. This includes all prescriptions, over-the-counter drugs, vitamins, and supplements to improve health and safety and prevent medication errors.
  • The FDA updated its outbreak advisory on Salmonella Typhimurium infections linked to cucumbers from Agrotato, S.A. de C.V. in Sonora, Mexico. Following recalls and investigation, the CDC has declared the outbreak over.

Additional Resources: 

  •  

Media Contact: , 301-796-4540 
Consumer Inquiries: 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.

U.S. Food and Drug Administration (FDA) logo (PRNewsfoto/FDA)

 

SOURCE U.S. Food and Drug Administration

elong